Cite
HARVARD Citation
Rolfes, L. et al. (2021). Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurology. 8 (5), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rolfes, L. et al. (2021). Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurology. 8 (5), p. . [Online].